ILCA joint session
1st ILCA-CIRSE COLLABORATIVE SESSION
Thursday, April 10
The CIRSE Foundation is pleased to welcome ILCA for a joint session during ECIO 2008.
The International Liver Cancer Association (ILCA) is the only international organisation devoted exclusively to liver cancer research for experts from all related disciplines. If you would like to learn more about ILCA please refer to www.ilca-online.org
Thursday, April 10
10:00-12:00
Blending interventional radiology and molecular medicine in HCC
Epidemiology and diagnosis of hepatocellular carcinomaChairs: J. Bruix (Barcelona/ES), J. Lammer (Vienna/AT)
Risk factors and cost-effective screening
M. Beaugrand (Paris/FR)
Imaging techniques for diagnosis and staging
B. Choi (Seoul/KR)
Tumour biospy: entering molecular staging
T. Roskams (Leuven/BE)
Outcome prediction: how to refine
J. Bruix (Barcelona/ES)
Interventional radiology and molecular medicine
Chairs: J. Bruix (Barcelona/ES), B. Choi (Seoul/KR)
Assessment of gene expression by imaging
M. Kuo (SanDiego, CA/US)
Functional imaging to assess molecular therapy
V. Vilgrain (Clichy/FR)
Is RECIST still valuable in hepatcellular carcinoma
R. Lencioni (Pisa/IT)
Targeting molecular pathways in the adjuvant setting after locoregional treatment
J.M. Llovet (Barcelona/ES)

Copyright © CIRSE Foundation (Cardiovascular and Interventional Radiological Society of Europe)




Back
Top